Officially, the FDA cites: Insufficient large-scale clinical trials Concerns about consistency, sourcing, and manufacturing standards The need to meet formal drug approval requirements Critics argue (fairly) that this system: Favors large pharmaceutical companies Makes it hard to approve naturally occurring peptides Leaves promising, low-risk compounds in regulatory limbo The short version: This FDA restrictive regulatory change of mind wasnt driven by a sudden safety scare, it was driven by regulatory process and economics
The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market
Despite cost-containment measures, GLP1 coverage continues to evolve
Clinical Update 11/14/2023 Aluminum Exposure from Coffee
Difficulty Staying Hydrated If you feel like drinking water alone is not enough, or you struggle to stay hydrated even when you are trying, electrolytes may help support balance
A balanced diet can help your body produce more glutathione naturally and take the most out of external sources